Connect with us

Technology

Slone Partners Places Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences

Published

on

Industry veteran brings more than 25 years of experience in senior leadership roles

SOUTH RIDING, Va., May 29, 2024 /PRNewswire-PRWeb/ — Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences, a preclinical therapeutics company whose technology targets transcriptional dysregulation in disease.

Kevin Eastwood is a highly accomplished and dynamic business leader with extraordinary passion and vision and a track record of success,” said Leslie Loveless, CEO and Managing Partner at Slone Partners.

Eastwood has more than 25 years of experience in senior leadership roles at innovative pharmaceutical and therapeutics companies across the nation. Most recently he served as Executive Vice President, Corporate Development at Plexium, Inc., where he helped secure a $35M series A-2 financing and $102M series B financing and established two multi-target, multi-year drug discovery collaborations, one with Amgen in the oncology disease area and a second with AbbVie in neuroscience. In prior roles, Eastwood served as Vice President, Corporate Development at the California Institute for Biomedical Research and the Scripps Research Institute; Senior Director, Corporate Development, Gilead Sciences, Inc.; and Startup Founder and Senior Vice President, Corporate Development, Effector Therapeutics, Inc.

Kevin Eastwood is a highly accomplished and dynamic business leader with extraordinary passion and vision and a track record of success,” said Leslie Loveless, CEO and Managing Partner at Slone Partners. “He brings a high level of strategic management and business development to the outstanding leadership team at Arpeggio.”

“We are thrilled to join forces with Kevin. With over 20 years of experience in business development, at Gilead and platform technology companies like Plexium and Ambrx, Kevin is the ideal person to elevate our functional genomics approach to targeting transcription factors to new heights,” said Joey Azofeifa, CEO at Arpeggio.

“I am grateful for the opportunity to join Arpeggio Biosciences to support its mission to transform the discovery of therapeutics that correct dysregulated transcription,” Eastwood stated. “Arpeggio’s HTS transcriptomics platform GRETA™ provides a novel approach for identifying small molecule transcription modulators, providing an opportunity to drug transcription factors, historically viewed as undruggable targets.”

Eastwood earned his B.S. in biology/chemistry from Missouri State University.

ABOUT SLONE PARTNERS
Founded in 2000, Slone Partners is a premier nationwide executive search firm that delivers visionary leaders who build amazing life sciences and healthcare organizations. With a nationwide presence in the most active industry hubs, we specialize in discovering and placing world-class Board, C-Suite leadership, and upper management talent with experience, conviction, and cultural competence in emerging and well-established companies. Our portfolio of executive search and advisory services includes customized cultural solutions through strategic planning, education, training, and coaching. Slone Partners proudly holds the designation as a Certified LGBT Business Enterprise™ by the National Gay & Lesbian Chamber of Commerce (NGLCC) and has earned recognition as a Top Executive Search Firm and a Top 20 Diversity and Inclusion Services firm by Manage HR. To learn more about Slone Partners’ value proposition and processes, visit https://www.slonepartners.com or call 888.784.3422.

ABOUT ARPEGGIO BIOSCIENCES
Arpeggio Biosciences is drugging transcription factors using AI and rapid RNA-sequencing. Powered by laboratory automation, Arpeggio discovers drugs based on not just a single target, but the entire cellular network. Arpeggio is currently progressing drug programs towards clinical studies in oncology and chronic kidney disease. To learn more, visit http://www.arpeggiobio.com.

Media Contact

Doug Gavel, Doug Gavel Communications, (617) 429-4417, doug.gavel@gmail.com, http://www.douggavel.com

View original content to download multimedia:https://www.prweb.com/releases/slone-partners-places-kevin-eastwood-as-chief-business-officer-at-arpeggio-biosciences-302157157.html

SOURCE Slone Partners

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

BingX Introduces ALTCOIN Index Futures Trading: One Click, Countless Trends

Published

on

By

VILNIUS, Lithuania, Dec. 27, 2024 /PRNewswire/ — BingX, a global leading cryptocurrency exchange, is excited to announce the launch of ALTCOIN Index, the first futures trading pair involving top altcoins. This innovative trading product offers users a one-click solution to efficiently track and trade major cryptocurrency trends with ease.

Traditionally used in stock markets, a futures index is a financial derivative that tracks the performance of a group of assets, such as stocks of commodities. These instruments were first introduced to simplify trading by allowing investors to speculate on or hedge against the collective movements of selected market sectors. Instead of purchasing individual stocks, traders are able to access broad market exposure in a single transaction, saving time and reducing costs.

In the cryptocurrency market, this new ALTCOIN/USDT futures trading pair works similarly by bundling the performance of the top mainstream cryptocurrencies by market capitalization, excluding Bitcoin (BTC) and stablecoins. The current index includes ETH, XRP, SOL, BNB, DOGE, ADA, TRX, AVAX, and SHIB. This approach is more efficient compared to buying individual cryptocurrencies or ETFs as this allows for direct speculation using tiered leverage options without the need to manage multiple positions, effectively diversifying trading risks associated with individual asset volatility.

Vivien Lin, Chief Product Officer of BingX, commented on the new offering: “By aggregating a range of leading cryptocurrencies into a single trading instrument, we’re giving users a practical and efficient way to better capture market trends. This index trading pair should help our less experienced users with their trading goals more easily, particularly when they are unsure which asset to trade and just want to trade major altcoins in general with leverage.”

BingX users can take advantage of tiered leverage options and competitive rates consistent with the platform’s perpetual futures terms, simplifying open order management and enhancing trading efficiency. The platform also ensures that the index composition remains current, with regular quarterly adjustments and temporary updates in response to market conditions.

About BingX
Founded in 2018, BingX is a leading crypto exchange, serving over 10 million users worldwide. BingX offers diversified products and services, including spot, derivatives, copy trading, and asset management – all designed for the evolving needs of users, from beginners to professionals. BingX is committed to providing a trustworthy platform that empowers users with innovative tools and features to elevate their trading proficiency. In 2024, BingX proudly became the official crypto exchange partner of Chelsea Football Club, marking an exciting debut in the world of sports.

For more information please visit: https://bingx.com/

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/bingx-introduces-altcoin-index-futures-trading-one-click-countless-trends-302339488.html

SOURCE BingX

Continue Reading

Technology

Lyric’s first solid-state battery front-end equipment is shipped to customer in United States

Published

on

By

BEIJING, Dec. 26, 2024 /PRNewswire/ — Recently, Lyric’s first solid-state battery front-end equipment has been shipped to a customer in the United States. Relying on its deep accumulation in the field of solid-state battery technology, Lyric has achieved strategic development on the global stage.

As of now, Lyric’s Z-shape stacking machine has reached the forefront of the industry, achieving an efficient stacking speed of 0.1s/pcs and ultra-high precision alignment of ≤ ± 0.3mm, setting an industry benchmark. At the same time, with the innovative design, the double planetary mixer realizes the efficient mixing of various viscosity materials, showing extraordinary flexibility, and significantly enhances the safety and efficiency of the production process through the iterative upgrade of automation technology, and provides customized services to accurately meet customer needs.

Looking to the future, Lyric will continue to expand its global footprint, based on the deep accumulation in the field of solid-state batteries since 2020, and its patented technology of dry electrode and stacking process and self-developed equipment advantages, Lyric not only demonstrates excellent capabilities in the manufacture of solid-state battery production equipment, but also provides a full range of solutions. Covers customized delivery from a single station to the entire production line. In terms of international cooperation, Lyric is actively seeking cooperation opportunities with more overseas enterprises, aiming to promote China’s solid-state battery equipment technology and solutions to the global market, further enhance its influence and competitiveness in the global renewable energy industry chain, and jointly explore unlimited possibilities in the field of renewable energy.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lyrics-first-solid-state-battery-front-end-equipment-is-shipped-to-customer-in-united-states-302339490.html

SOURCE Lyric

Continue Reading

Technology

Life-Space Wins Prestigious 62nd Australian Export Awards

Published

on

By

MELBOURNE, Australia, Dec. 27, 2024 /PRNewswire/ — At the prestigious 62nd Australian Export Awards held at Parliament House in Canberra, Life-Space, Australia’s No. 1 probiotic brand, proudly claimed the title of ‘E-commerce Winner of the Australian Export Awards 2024’. This incredible achievement underscores Life-Space’s unwavering commitment to delivering world-class health solutions to global consumers, fuelled by innovative digital strategies and a robust e-commerce presence.

Celebrating Australian Export Excellence

The Australian Export Awards, established in 1963 and presented by the Australian Trade and Investment Commission (Austrade) in collaboration with State and Territory awards programs, is a premier national program. It recognises the achievements of Australia’s most outstanding, innovative, and inspiring exporters, highlighting their significant contributions to the nation’s economy.

A Global Leader in Consumer Health

Life-Space has established itself as a trusted name in probiotics, offering products that support gut microbiome and whole-body health. Exporting to over 20 countries, including China and key Southeast Asian markets, Life-Space continues to redefine the global consumer health landscape. The brand’s dedication to scientific innovation, high-quality manufacturing, and consumer education has made it a household name worldwide. 

Driving E-commerce Excellence

The award recognises Life-Space’s exceptional ability to adapt to the ever-evolving digital marketplace. Through strategic collaborations, robust online platforms, and consumer-centric marketing campaigns, Life-Space has consistently delivered value to its customers while expanding its global footprint. Notably, Life-Space has seen explosive growth in China’s cross-border e-commerce market, alongside outstanding performance in Southeast Asian countries such as Singapore, Vietnam, and Malaysia. The Singapore market, in particular, has recorded an impressive 140% annual growth rate for three consecutive years.

‘This recognition is a testament to the passion and hard work of the entire Life-Space team,’ said Alan Yi, Life-Space Group’s General Manager – Global Business, ‘We are proud to represent Australia on the global stage and remain dedicated to bringing the best in probiotics to consumers worldwide.’

Looking Ahead

As Life-Space celebrates this milestone, the brand is focused on forging new market opportunities, advancing health education, and introducing cutting-edge products that enhance everyday health and well-being.

“Our vision for 2025 includes expanding our export capacity and preparing to introduce our products to the U.S. market,” added Yi. “This achievement further reinforces our position as a global leader in consumer health.”

View original content:https://www.prnewswire.com/apac/news-releases/life-space-wins-prestigious-62nd-australian-export-awards-302339494.html

SOURCE Life-Space

Continue Reading

Trending